Single and Double Dose of 2009 Pandemic Influenza A H1N1 Vaccine are equally immunogenic in HIV-infected adolescents and young adults

Trial Profile

Single and Double Dose of 2009 Pandemic Influenza A H1N1 Vaccine are equally immunogenic in HIV-infected adolescents and young adults

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2011

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine; MF 59
  • Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype; Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2011 Results published in Clinical and Vaccine Immunology.
    • 15 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top